☆ 4.7 Article

A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Regulation of the tumor suppressor PTEN in triple-negative breast cancer

Chengsen Chai et al.

Summary: This review focuses on the role and regulation of PTEN in triple-negative breast cancer (TNBC). PTEN inactivation is associated with aggressive tumor phenotype and plays a crucial role in negatively regulating cell proliferation and migration. The review provides a summary of genomic alterations of PTEN, discusses the transcriptional regulation and posttranslational modifications of PTEN, and explores the prospects of PTEN protein in TNBC.

CANCER LETTERS (2022)

添加到收藏夹

Article Chemistry, Applied

The effects of zinc(II)phthalocyanine photosensitizers on biological activities of epitheloid cervix carcinoma cells and precise determination of absorbed fluence at a specific wavelength

Asiye Gok Yurttas et al.

Summary: This study investigated the use of zinc photosensitizers in photodynamic therapy for cancer treatment, analyzing the efficiency of two different photosensitizers through experiments and calculations. The research provides valuable insights for the future application of these photosensitizers in cancer therapy.

DYES AND PIGMENTS (2022)

添加到收藏夹

Article Chemistry, Applied

A novel zinc phthalocyanine-indometacin photosensitizer with Three-in-one cyclooxygenase-2-driven dual targeting and aggregation inhibition for high-efficient anticancer therapy

Kunshan Huang et al.

Summary: Introducing indomethacin to conjugate with zinc phthalocyanines successfully addresses the issues of photosensitizer aggregation, poor tumor targeting, and limited action radius of reactive oxygen species. The designed photosensitizer IMC-Pc shows improved efficiency in intracellular reactive oxygen species generation and anticancer efficacy through cyclooxygenase-2-driven dual targeting and aggregation inhibition.

DYES AND PIGMENTS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity

Qinyanqiu Xiang et al.

Summary: This study developed a FeWOx-PEG nanoadjuvant that enhances immune therapy through photothermal therapy and immunogenic cell death. The nanoadjuvant can eliminate primary tumors and suppress the growth of distant tumors under the guidance of magnetic resonance/computed tomography/photoacoustic imaging.

SMALL (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy

Bin Ji et al.

Summary: Cancer immunotherapy has shown great progress in advanced-stage malignancies, but low response rates and immunosuppressive tumor microenvironments limit its effectiveness. Photodynamic therapy (PDT) can induce immunogenic cell death and enhance immune responses. Recent nanomedicine-based strategies have improved the efficiency of PDT and immunotherapy, and synergistic nanotherapeutics have been used to amplify immune responses. Challenges and future expectations in PDT-driven cancer immunotherapy are discussed.

THERANOSTICS (2022)

添加到收藏夹

Article Optics

Orthogonal Aza-BODIPY-BODIPY dyad as heavy-atom free photosensitizer for photo-initiated antibacterial therapy

Dongliang Yang et al.

Summary: A novel halogen-free photosensitizer, NDB, was synthesized in this study. The ROS generation capability of NDB under 730 nm laser illumination was found to be 3-fold higher than that of the commercial ICG, suggesting its potential application in photo-initiated antibacterial therapy.

JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES (2022)

添加到收藏夹

Review Oncology

Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?

Emma E. Newton et al.

Summary: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer, which is more likely to metastasize and resist treatment than other forms of breast cancer due to its heterogeneity and lack of hormone receptor expression. Chemotherapy and surgery have been the main treatment options for TNBC, but resistance to chemotherapy and tumor recurrence are common. Emerging immunotherapies targeting immune pathways and other therapeutic options inhibiting key cellular growth pathways have shown promising results in improving survival for TNBC patients. Continued research on immunotherapy and neoadjuvant therapy is expected to change the treatment course for TNBC in the future.

CANCERS (2022)

添加到收藏夹

Article Oncology

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

Xinyu Zhou et al.

Summary: Combining transferrin and dihydroartemisinin enhances cell death in triple-negative breast cancer cells induced by TRAIL. This combination therapy triggers more cell death by increasing DR5 expression in sensitive cells.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

EGFR-Targeted Photodynamic Therapy

Luca Ulfo et al.

Summary: EGFR-targeted photodynamic therapy is a promising approach for cancer treatment, which selectively delivers photosensitizers to tumor environments. This review summarizes recent nanobiotechnological advancements combining photodynamic therapy with EGFR-targeted molecular cancer therapy, highlighting its advantages, drawbacks, and future perspectives.

PHARMACEUTICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling

Alessandra Fiore et al.

Summary: This study uncovers an unrecognized link between IDO1 and cell survival mediated by KYN, which inhibits ferroptotic cell death. The findings highlight the need to re-evaluate the use of IDO1 inhibitors in cancer treatment.

MOLECULAR CELL (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Dapagliflozin Reduces Apoptosis of Diabetic Retina and Human Retinal Microvascular Endothelial Cells Through ERK1/2/cPLA2/AA/ROS Pathway Independent of Hypoglycemic

Yuxin Hu et al.

Summary: The study revealed that dapagliflozin can slow the progression of diabetic retinopathy by reducing apoptosis of retinal cells, and alleviate HRMECs apoptosis induced by high glucose through the ERK/1/2/cPLA2/AA/ROS pathway.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles

Luis Exequiel Ibarra et al.

Summary: Photodynamic therapy (PDT) may be a promising alternative for the treatment of breast cancer, especially for aggressive types like triple-negative breast cancer (TNBC). A recent study explored the use of conjugated polymer nanoparticles (CPNs) as photosensitizers for targeted PDT. By attaching unique 2'-Fluoropyrimidines-RNA-aptamers to the surface of CPNs, the researchers aimed to improve the selectivity of the treatment for TNBC cells. Results showed that CL4, sTN29, and sTN58 aptamers were effective in selective tumor targeting and improving PDT efficacy in TNBC cells.

PHARMACEUTICS (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Progress of Nanomaterials in Photodynamic Therapy Against Tumor

Lei Chen et al.

Summary: Photodynamic therapy (PDT) is an advanced therapeutic strategy that has been widely used in the clinical treatment of solid tumors. Various strategies, including improving photosensitizers delivery and tumor microenvironment, as well as synergistic treatment with other therapies, have been investigated to enhance the efficacy of PDT.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

添加到收藏夹

Article Oncology

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

Haven R. Garber et al.

Summary: Patients with hereditary mutations in BRCA1 or BRCA2 have a higher risk of brain metastasis, with BRCA1 carriers being more affected. The presence of brain metastasis negatively impacts overall survival, highlighting the need to improve prevention and treatment strategies for brain metastasis in TNBC, gBRCA1 carriers, and noncarriers.

NPJ BREAST CANCER (2022)

添加到收藏夹

Article Oncology

Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

Hye Sung Won et al.

Summary: HER2-low breast cancer and HER2-IHC 0 breast cancer have different clinicopathological characteristics and survival outcomes. HER2-low breast cancer is more common in hormone receptor-positive breast cancer but is associated with a high lymph node ratio and positive lymphatic invasion in triple-negative breast cancer. HER2-low breast cancer shows significantly better breast cancer-specific survival compared to HER2-IHC 0 breast cancer. These findings suggest that the biology and clinical impact of low HER2 expression may vary according to the hormone receptor status.

BREAST CANCER RESEARCH (2022)

添加到收藏夹

Article Engineering, Biomedical

Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate

Yang Lu et al.

Summary: NBS-1MT, an organic photo-immune activator, effectively triggers pyroptosis and disrupts the suppressive tumor microenvironment, activating the immune response and inhibiting tumor growth.

BIOMATERIALS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions

Minru Liao et al.

Summary: TNBC, the most aggressive subtype of breast cancer, lacks effective targeted therapy. Novel small-molecule drugs targeting specific molecular characteristics of TNBC may be a promising intervention, but face challenges. Emerging strategies such as dual-target drugs, drug repurposing, and combination strategies offer new insights for improving TNBC therapeutics.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Oncology

Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer

Elizabeth A. Wilson et al.

Summary: In ER-negative breast cancer cells, inhibiting RRM2 can reduce cell proliferation by decreasing NF-kB activity, and the combination of didox and doxorubicin significantly reduces TNBC cell proliferation. Combination therapy shows synergistic effects in vivo, reducing tumor volume, and didox can mitigate the toxic myocardial effects of doxorubicin.

MOLECULAR CANCER THERAPEUTICS (2021)

添加到收藏夹

Article Oncology

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer

Peng Li et al.

Summary: The study found that IDO1 and PD-L1 were highly expressed in TNBC patients, and Vγ9Vδ2 T cells became exhausted in these patients. Combining Vγ9Vδ2 T cells with IDO1 inhibitor may be applicable for TNBC treatment.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis

Liuwan Zhao et al.

JOURNAL OF CONTROLLED RELEASE (2020)

添加到收藏夹

Article Nanoscience & Nanotechnology

Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy

Yang Lan et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

添加到收藏夹

Article Engineering, Biomedical

Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation

Huiyuan Zhang et al.

BIOMATERIALS (2020)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of indoximod prodrugs and characterization of clinical candidate NLG802

Sanjeev Kumar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia

Gankun Yuan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets

Zhe Yang et al.

ACS NANO (2020)

添加到收藏夹

Review Oncology

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype

Andrea Angius et al.

CANCERS (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Nanosoldiers: A promising strategy to combat triple negative breast cancer

Akshayya Pawar et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

被撤回的出版物: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression (Retracted article. See vol. 21, 2022)

Rui Yang et al.

MOLECULAR CANCER (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication

Wen Song et al.

ACS NANO (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Directed Graphene-Based Nanoplatforms for Hyperthermia: Overcoming Multiple Drug Resistance

Zhaoxu Tu et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy

Guan-Jun Yang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

添加到收藏夹

Article Pathology

IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1

Erik A. Dill et al.

MODERN PATHOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

Mihriban Karaayvaz et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

P. Calleja et al.

PHARMACOLOGICAL RESEARCH (2017)

添加到收藏夹

Review Oncology

Reactive oxygen species in redox cancer therapy

Lingying Tong et al.

CANCER LETTERS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Kari R. Fischer et al.

NATURE (2015)

添加到收藏夹

Article Oncology

Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy

Veronique Nogueira et al.

CLINICAL CANCER RESEARCH (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Spectroscopic Investigations on the Binding of the Photosensitizer Chlorin p6 with Amine-modified Silica Nanoparticles in Aqueous Media

Beena Jain et al.

PHOTOCHEMISTRY AND PHOTOBIOLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.